论文部分内容阅读
近年来,对肝细胞癌(HCC),除施行肝动脉栓塞疗法(TAE),酒精注射疗法外,还在施行肝切除治疗,欧美还进行肝移植。随着肝脏外科的进步,可以收集到相当多数量的HCC 肝切除病例,因此,有必要对HCC 治疗方法加以评价。外科治疗的评价包括,手术适应证、术后并发症、术后死因及生存率。最近不论在哪家医疗部门手术死亡率都在不断降低,引人关注的是术后长期生存率。在此就这一问题论述作者们的疗效和见解。
In recent years, in addition to hepatic artery embolization (TAE) and alcohol injection therapy, hepatocellular carcinoma (HCC) is also undergoing hepatectomy. Europe and the United States also perform liver transplantation. With the advancement of liver surgery, a considerable number of cases of HCC hepatectomy can be collected. Therefore, it is necessary to evaluate HCC treatment methods. Evaluation of surgical treatment included indications for surgery, postoperative complications, postoperative causes of death, and survival rates. In recent years, the surgical mortality rate has been continuously decreasing in any medical department, and the long-term survival rate is of concern. Discuss the author’s efficacy and insights on this issue.